Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies
Open Access

Investigation of the Relationship Between Adrenal Gland Signal Intensity and Age in Whole-body MRI/DWIBS

TOMOMI MOHRI, YUKINORI OKADA, YO UCHIYAMA, SUSUMU SAIGUSA, HIROYUKI FUJIKAWA, HIROYUKI SAKURAI, KOJI TANAKA, SEIYA WADA, MASATOMO NISHIDA, HIROMITSU UEDA, KATSUNORI TSUJII, TOMONARI GOTO, KENICHI YASUMOTO, AYAMI ZENZAI, DAIYA HAYASHI, ASUKA NAKATANI, CHIHIRO KAZAMA and KAZUHIRO SAITO
In Vivo January 2026, 40 (1) 364-371; DOI: https://doi.org/10.21873/invivo.14200
TOMOMI MOHRI
1Department of Breast Surgery, IGA City General Hospital, Iga, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: t-mohri{at}iga-med.jp
YUKINORI OKADA
2Department of Radiology, IGA City General Hospital, Iga, Japan;
3Department of Radiology, Tokyo Medical University, Tokyo, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: okadayu{at}tokyo-med.ac.jp
YO UCHIYAMA
4Department of Surgery, IGA City General Hospital, Iga, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SUSUMU SAIGUSA
4Department of Surgery, IGA City General Hospital, Iga, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HIROYUKI FUJIKAWA
4Department of Surgery, IGA City General Hospital, Iga, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HIROYUKI SAKURAI
4Department of Surgery, IGA City General Hospital, Iga, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KOJI TANAKA
4Department of Surgery, IGA City General Hospital, Iga, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SEIYA WADA
5Department of Radiation Technology, IGA City General Hospital, Iga, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MASATOMO NISHIDA
5Department of Radiation Technology, IGA City General Hospital, Iga, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HIROMITSU UEDA
5Department of Radiation Technology, IGA City General Hospital, Iga, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KATSUNORI TSUJII
5Department of Radiation Technology, IGA City General Hospital, Iga, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TOMONARI GOTO
5Department of Radiation Technology, IGA City General Hospital, Iga, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KENICHI YASUMOTO
5Department of Radiation Technology, IGA City General Hospital, Iga, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AYAMI ZENZAI
5Department of Radiation Technology, IGA City General Hospital, Iga, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DAIYA HAYASHI
5Department of Radiation Technology, IGA City General Hospital, Iga, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ASUKA NAKATANI
5Department of Radiation Technology, IGA City General Hospital, Iga, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHIHIRO KAZAMA
5Department of Radiation Technology, IGA City General Hospital, Iga, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KAZUHIRO SAITO
3Department of Radiology, Tokyo Medical University, Tokyo, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background/Aim: To identify factors influencing adrenal signal intensity in whole-body magnetic resonance imaging/diffusion-weighted whole-body imaging with background body signal suppression (MRI/DWIBS).

Patients and Methods: This retrospective study included patients who underwent whole-body MRI/DWIBS at our institution between April 2019 and April 2025 with no malignant tumor or history of a malignant tumor. Adrenal signal intensity and gland area were measured and analyzed according to sex and age.

Results: The study included 22 male patients (average age of 58.2±11.7) and 38 female patients (average age of 55.9±15.4). The maximum signal intensity (max value) of the left adrenal gland on diffusion-weighted imaging was 1,885.5±352.0, and the mean gland area was 1,198±435.0 mm2 in male patients, and 1,517.1±429.5 and 760.5±325.6 mm2, respectively, in female patients. The median values for max value of the left adrenal gland on diffusion-weighted imaging were significantly larger in male patients (male: 1855 vs. female: 1,472, p<0.01). The median value for adrenal gland area was significantly larger in male patients (male: 1,159 mm2 vs. female: 768.5 mm2, p<0.01). Among female patients, those aged <40 years had a significantly lower median max value and adrenal gland area compared to those aged ≥40 years (<40 years: 1,004 vs. ≥40 years: 1,603, p<0.01 and <40 years: 478 mm2 vs. ≥40 years: 834 mm2, p=0.017, respectively).

Conclusion: Adrenal gland signal intensity and gland size on whole-body DWIBS are significantly higher in males than in females. In females, both signal intensity and adrenal area increase with age, suggesting age-related physiological or hormonal influences on adrenal gland characteristics.

Keywords:
  • Adrenal signal
  • hydrogen atoms
  • body imaging with background body signal suppression
  • MRI/DWIBS
  • signal intensity

Introduction

Magnetic resonance imaging (MRI) is a technique used to visualize the dynamics of hydrogen atoms in living organisms. Recently, whole-body diffusion-weighted imaging has been employed to perform comprehensive systemic examinations. In particular, diffusion weighted whole body imaging with background body signal suppression (DWIBS) enables imaging during free breathing. In this technique, the b-value in diffusion-weighted imaging is set high, typically between 800s/mm2 to 1,000s/mm2, to effectively suppress natural background signals from tissue (1). DWIBS is widely used in the diagnosis of malignant tumors that require whole-body examination.

Cancerous lesions, such as those found in breast cancer, exhibit high signal intensity in diffusion-weighted imaging because the free movement of water molecules is restricted (2). In the breast, malignant lesions generally have longer T1 relaxation times than benign lesions (3). The Short T Inversion Recovery (STIR) sequence suppresses signals from tissues with short T1 values, whereas tissues with long T1 values are less affected. Consequently, STIR may be particularly useful for detecting malignant tumors.

A comparative study between positron emission tomography (PET) using 18F-fluoro deoxy glucose (18F-FDG), a glucose analog, and DWIBS was conducted on 16 patients with malignant tumors (12 with lung cancer, two with colorectal cancer, one with breast cancer, and one with lung metastasis), comprising 27 lesions in total. DWIBS successfully identified 25/27 lesions, while PET detected 22/27 (4). However, image interpretation often involves not only DWIBS, but also complementary sequences, including whole-body diffusion-weighted, T1-weighted, T2-weighted, and fusion images acquired simultaneously.

One major challenge in image interpretation is the physiological variation in signal intensity among healthy organs. The adrenal glands, located above the kidneys and prone to distant metastasis, may also be affected by benign or unrelated conditions such as adenomas and hyperplasia, necessitating careful evaluation. Anatomically, the adrenal glands are divided into two regions: the adrenal medulla and the adrenal cortex, both of which play crucial roles in endocrine function. The medulla, located medially to the kidney, produces catecholamines such as adrenaline. The cortex, located peripherally, secretes several hormones, including cortisol, aldosterone, and dehydroepiandrosterone (5).

Despite advancements in imaging, several clinical questions remain unanswered: 1) Is there a difference in adrenal signal intensities between males and females in MRI imaging? and 2) does the adrenal signal intensity vary with age? This study aims to examine the influence of sex and aging on adrenal gland signal intensities in MRI.

Patients and Methods

Patient selection. This was a single-center, retrospective, patient-control study. Patients who underwent DWIBS for a health checkup, evaluation of elevated tumor markers, fever of unknown origin, or workup for a suspected tumor at Iga City General Hospital between April 2019 and April 2025, and in whom no malignant tumor was identified, were included in the study. Patients who did not provide consent to participate in the study, those with a history of malignant tumors, those suspected of having a malignant tumor on DWIBS, and patients with and bowel inflammation (acute diverticulitis) were excluded.

DWIBS examination. In this study, DWIBS imaging was performed using an Inginia 1.5T MRI system (Philips; Tokyo, Japan and Amsterdam, the Netherlands). The diffusion weighted imaging protocol was set as follows: repetition time (TR)=5,000 ms, echo time (TE)=66 ms, single-shot echo planar imaging (EPI), bandwidth=42.3 Hz, field of view (FOV)=460 mm (frequency)×316 mm (phase), matrix size=128×86, slice thickness=7 mm, voxel size=3.59×3.54 mm, number of excitations (NEX)=2, and parallel imaging with free-breathing acquisition. Three types of coils were used: a head and neck coil, a body coil, and an anterior coil. The body was divided into three regions for imaging. Two of the three coils were combined as appropriate for each region, and the final result was reconstructed as a single composite whole-body image.

Using the aforementioned MRI system, the following images were obtained: (1) a DWIBS maximum intensity projection (MIP) images; (2) transverse diffusion-weighted images, (3) transverse apparent diffusion coefficient (ADC) images, (4) coronary diffusion-weighted images, (5) coronary T1-weighted images, (6) coronary STIR images, (7) transverse in phase/out phase images, and (8) fusion images. These imaging methods collectively constitute the DWIBS examination in this study.

For image analysis, a radiation oncologist and nuclear medicine specialist (Y.O) with DWIBS imaging experience from 2016 manually set the region of interest (ROI) on the left adrenal gland on transverse diffusion-weighted images, referencing anatomical landmarks. The left adrenal gland was selected because the right adrenal gland often overlaps with the liver, which can interfere with accurate measurement. The maximum signal intensity across all slices of the left adrenal gland was recorded on the transverse diffusion-weighted images. In addition, the ROI was used to calculate the area (mm2) of left adrenal gland.

In diffusion-weighted imaging, the signal intensity obtained without the application of a gradient field is defined as the b value (S0), and the signal intensity after application is defined as the diffusion coefficient (D).

Embedded Image (6)

One transverse ADC images, the maximum ADC (max ADC) signal intensity of the left adrenal gland was measured across all slices. The b value was set constant at 1,000 s/mm2.

Image evaluation was performed using a reporting terminal system (PSP, Japan, Tokyo) and an RX660 monitor (EIZO, Ishikawa, Japan). On this monitor, pixel brightness corresponds directly to signal intensity; therefore, pixel brightness was used as the measured signal intensity in this study, particularly for whole body DWI image.

The ADC value is calculated by the following formula: ADC value=(Pixel value×0.0409225)×Real World Slope + (0.0409225×Real World Intercept).

In this system, numerical values are displayed without units. Therefore, in this study, the measured values were standardized and expressed relative to the conventional ADC scale.

Statistical analysis. Statistical analysis was performed using eZR, developed by the Omiya Medical Center of Jichi Medical University (7). Comparison between the two groups was made using the Mann-Whitney U test. Spearman’s rank correlation coefficient was used to calculate the correlation coefficient. p-Values of <0.05 were considered statistically significant.

Ethical considerations and informed consent. This study was performed with the approval of the Ethics Committee of IGA City General Hospital (medical examination No. 344 and 564, DWIBS No. 92). An opt-out option was applied for all patients receiving regular medical examinations. The study’s aims and procedures were explained to all health checkup patients, and a written informed consent to use data for the study was obtained. For patients whose data was collected up to March 2025, the opt-out procedure (No. 92) was implemented. For patients examined from April 2025 onward, written informed consent was directly obtained.

Results

Patients. Overall, 60 patients were included in this study. Six patients were excluded: two patients with a past history of cancer, one patient with prostate cancer, one patient with a suspected tumor, one patient with acute bowel inflammation and rheumatism, and one patient who did not consent. Among the participants, one female patient with polymyositis/dermatomyositis who was receiving steroid therapy was also included.

Comparison between male and female. A total of 22 male patients were analyzed, with a mean age of 58.2±11.7 years (median, 55 years). ADC images were not available for one male patient. The female group included 38 patients with a mean age of 55.9±15.4 years (median=53.5 years), and ADC images were unavailable for two female patients. There was no statistically significant difference in age between males and females (p=0.447). In males, the maximum signal intensity of the left adrenal gland on diffusion-weighted imaging was 1,885.5±352.0, with a median value of 1,855. The mean area of the left adrenal gland was 1,198.0±435.0 mm2, with a median of 1,159 mm2. The maximum ADC value of the left adrenal gland was (2.02±0.26)×10−3 mm2/s, with a median of 1.894×10−3 mm2/s.

In females, the maximum signal intensity of the left adrenal gland on diffusion-weighted imaging was 1,517.1±429.5, with a median value of 1,472. The mean adrenal area was 760.5±325.6 mm2, with a median of 768.5 mm2. The maximum ADC value was (1.96±0.46)×10−3 mm2/s, with a median of 2.012×10−3 mm2/s. These results are summarized in Table I.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table I.

Patients’ characteristics and results comparison between males and females.

Comparison between males and females. The median values for max value of the left adrenal gland on diffusion-weighted imaging were significantly larger in male patients (males: 1,855 vs. females 1,472, p<0.01). The median values for adrenal gland area were significantly larger in male patients (males: 1,159 mm2 vs. females: 768.5 mm2, p<0.01, Figure 1 and Figure 2). In contrast, there was no significant difference in the maximum ADC value between sexes (p=0.774).

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Signal intensity values of the adrenal glands in diffusion-weighted imaging in males and females.

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Median value for the left adrenal gland area in males and females.

Considerations in males. Among the 22 male patients, 12 were aged <60 years and 10 were aged ≥60 years. The median maximum diffusion-weighted imaging value for the left adrenal gland in diffusion-weighted imaging was 1,763.5 in patients aged <60 years and 1,859.5 in patients aged ≥60 years, showing no significant difference (p=0.674). The median adrenal gland area was 1,134.0 mm2 in patients aged <60 years and 1,204.5 mm2 in patients aged ≥60 years, also showing no significant difference (p=0.42). The median maximum ADC value was 2.04×10−3mm2/s in patients aged <60 years and 1.86×10−3 mm2/s in patients aged ≥60 years, with no significant difference (p=0.57).

Considerations in females. Analysis at age 40. Seven female patients were aged <40 years and 31 were aged ≥40 years. The median maximum diffusion-weighted imaging value for the left adrenal gland was 1,004 for female patients <40 years and 1,603 for those aged ≥40 years, showing a significant difference (p<0.01, Figure 3). The median adrenal gland area was 478 mm2 for those <40 years and 834 mm2 for those aged ≥40 years, also showing a significant difference (p <0.01, Figure 4). The median maximum ADC value for the left adrenal gland area was 2.3×10−3 mm2/s for those aged <40 years and 2.0×10−3 mm2/s for those aged ≥40 years, showing a significant difference (p=0.038).

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

The median max values of the left adrenal gland in diffusion-weighted imaging in patients aged <40 years and those aged ≥40 years.

Figure 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 4.

The median values of the left adrenal gland area in diffusion-weighted imaging in patients aged <40 years and those aged ≥40 years.

Analysis at age 50. Thirteen female patients were aged <50 years and 25 were aged ≥50 years. The median maximum diffusion-weighted imaging value for the left adrenal gland was 1,341 for female patients aged <50 years and 1,603 for those aged ≥50 years, showing a significant difference (p= 0.025). The median value for the left adrenal gland area was 678 mm2 for those <50 years and 814 mm2 for patients aged ≥50 years, showing no significant difference (p=0.234). The median maximum ADC value was 2.1×10−3mm2/s for patients <50 years and 2.0×10−3mm2/s for those aged ≥50 years, showing no significant difference (p =0.165).

Analysis at age 60. Twenty-four female patients were aged <60 years and 14 aged ≥60 years. The median maximum diffusion-weighted imaging value for the left adrenal gland was 1,417 for female patients aged <60 years and 1,569 for those aged ≥60 years, showing no significant difference (p= 0.273), The median value for the left adrenal gland area was 777 mm2 for patients <60 years and 768.5 mm2 for those aged ≥60 years, showing no significant difference (p=0.754). The median maximum ADC value was 2.0×10−3mm2/s for patients <60 years and 2.1×10−3mm2/s for those aged ≥ 60 years, showing no significant difference (p=0.960).

Correlations. In female patients, a statically significant positive correlation was observed between age and the maximum signal intensity (r=0.329, p=0.043, Figure 5). No significant correlation was found between age and the maximum ADC value (r=−0.211, p=0.223). A representative plot illustrating the relationship between the maximum DWI signal intensity and the adrenal gland area is shown in Figure 5.

Figure 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 5.

Correlation between max value for the left adrenal gland on diffusion-weighted imaging and the age in females.

Discussion

This study demonstrated that, in a non-cancer-bearing population, the maximum signal intensity of the left adrenal gland in diffusion-weighted imaging is significantly higher in males than in females. Moreover, the left adrenal gland area was also significantly larger in males compared to females. In female patients, the maximum diffusion-weighted imaging value increased in those aged ≥40 years and ≥50 years compared to younger age groups, indicating that signal intensity changes with age. Similarly, the left adrenal gland area and maximum ADC values were higher in woman aged ≥ 40 years, although the relationship between diffusion-weighted imaging intensity and adrenal gland area was not entirely consistent.

According to the formula (1), the diffusion-weighted imaging signal intensity depends on the initial intensity (T2 weighted image), the b-value, and the ADC value. In this study, the b-value was held constant, suggesting that the variations in signal intensity were primarily influenced by the initial T2 weighted signal and ADC. A previous research study including 32 patients reported ADC values of 1.44×10−3 mm2/s in prepubertal subjects (age range=2.5 months-12 years; 4 males, 8 females), and in 1.23×10−3mm2/s in post-pubertal subjects (age range=11.9-60 years; 5 males, 15 females) (8). ADC values have also been shown to correlate positively with glomerular filtration rate in the kidney (9). However, in this study, there was no significant correlation between maximum diffusion-weighted imaging signal intensity and the maximum ADC value in either males or females, suggesting that the increased signal intensity cannot be attributed solely to diffusion.

Another possible contributor to the diffusion-weighted signal is the T2-weighted intensity itself, which forms the basis of the b=−0 s/mm2 measurement. Catecholamine production in the adrenal medulla increases with age (10-13), and older adult males produce more than younger ones (11, 12). Despite this, diffusion-weighted imaging signal intensity of the left adrenal gland did not appear to directly reflect catecholamine production.

Hormones synthesis in the adrenal cortex occurs via cholesterol metabolism (14). In the zona glomerulosa, aldosterone is synthesized via pregnenolone and progesterone (14); in the zona fasciculata, cortisol is produced via pregnenolone and 17OH-pregnenolone; and in the zona reticularis, DHEA, a precursor of dehydroepiandrosterone sulfate and potentially of androstenedione (14), is produced via pregnenolone and 17OH-pregnenolone (14). Androstenedione is a precursor of testosterone and potentially of estrone (14). 17β-estriol is produced from testosterone and estrone. Cholesterol levels fluctuate with age and sex. In a previous study involving 30,802 males and 60,417 females aged 40-79 years with no history of cardiovascular disease, mean low-density lipoprotein (LDL) cholesterol levels were slightly higher in females (15). A 2017 Japanese Ministry of Health, Labour and Welfare survey reported that the total and LDL-C cholesterol levels in females begins to rise after menopause, surpassing levels in males after the age of 50, while cholesterol levels in males remain relatively stable until their 60s and 70s (16, 17).

Considering these findings, it is plausible that the increased signal intensity of the adrenal glands reflects cholesterol uptake by the adrenal cortex and its subsequent conversion to pregnenolone, rather than the levels of individual adrenal hormones. This hypothesis is supported by our observation that the left adrenal gland area was larger in males than females, and that younger females (<40 years) had smaller adrenal gland areas than older females, potentially indicating age- and menopause-related shifts in cholesterol metabolism and adrenal hormone synthesis.

Unlike PET-CT imaging, which can be affected by physiological stress during 18F-FDG administration and lead to variable adrenal uptake (18-20), MRI, particularly DWIBS, is non-invasive and does not require contrast of radioactive tracers. Therefore, changes in adrenal signal intensity observed in DWIBS may more accurately reflect physiological function.

ADC values have been widely reported as useful quantitative indicators in oncology. Changes in ADC values are prognostic in locally advanced rectal cancer following chemoradiation therapy (21), predictive in 90Y-radioembolixation therapy (22), and used for staging in prostate cancer (23). These studies highlight the utility of ADC values as a quantitative measure; however, our results suggest that the diffusion-weighted image signal intensity itself may also serve as a valuable quantitative indicator of adrenal physiology.

Study limitations. First, it was retrospective in design. Second, the sample size was relatively small. Third, hormone levels and menopausal status were not directly evaluated, limiting the ability to correlate imaging findings with endocrine function. Future studies should prospectively investigate the relationship between adrenal diffusion-weighted imaging signal intensity, ADC values, and circulating hormone levels, including postmenopausal status, to better understand the physiological basis of adrenal imaging characteristics.

Conclusion

This study demonstrated that the maximum signal intensity of the left adrenal gland in whole-body diffusion-weighted imaging using DWIBS was significantly higher in males than females. In addition, age-related variation in adrenal signal intensity was observed among female patients.

Acknowledgements

We would like to express our gratitude to PSP Corporation and its employees for providing us with technical guidance.

Footnotes

  • Authors’ Contributions

    T.M.: conception (research idea), clinical data extraction; Y.O.: image data analysis; Y.U., S.S., H.F., H.S., K.T.: content check; S.W., M.N., H.U., K.T., T.G, K.Y, A.Z, D.H, A.N, C.K., M.U.: technical guidance concerning MRI.; K.S: final check and assessment concerning MRI.

  • Conflicts of Interest

    Y.O. was a member of Expert Imaging and Interventional Support (EIIS), undertaking the medical imaging reading at Iga City General Hospital. All other Authors declare no conflicts of interest for this study.

  • Funding

    No funding was used for this study.

  • Artificial Intelligence (AI) Disclosure

    No artificial intelligence (AI) tools, including large language models or machine learning software, were used in the preparation, analysis, or presentation of this manuscript.

  • Received August 22, 2025.
  • Revision received November 7, 2025.
  • Accepted November 12, 2025.
  • Copyright © 2026 The Author(s). Published by the International Institute of Anticancer Research.

This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY-NC-ND) 4.0 international license (https://creativecommons.org/licenses/by-nc-nd/4.0).

References

  1. ↵
    1. Kwee TC,
    2. Takahara T,
    3. Ochiai R,
    4. Nievelstein RA,
    5. Luijten PR
    : Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology. Eur Radiol 18(9): 1937-1952, 2008. DOI: 10.1007/s00330-008-0968-z
    OpenUrlCrossRefPubMed
  2. ↵
    1. Yamada T,
    2. Kanemaki Y,
    3. Okamoto S,
    4. Nakajima Y
    : Comparison of detectability of breast cancer by abbreviated breast MRI based on diffusion-weighted images and postcontrast MRI. Jpn J Radiol 36(5): 331-339, 2018. DOI: 10.1007/s11604-018-0731-6
    OpenUrlCrossRefPubMed
  3. ↵
    1. Lian C,
    2. Zhuang L,
    3. Wang Z,
    4. Liang J,
    5. Wu Y,
    6. Huang Y,
    7. Dai Y,
    8. Huang R
    : The diagnostic performance of T1 mapping in the assessment of breast lesions: A preliminary study. Eur J Radiol 177: 111589, 2024. DOI: 10.1016/j.ejrad.2024.111589
    OpenUrlCrossRefPubMed
  4. ↵
    1. Komori T,
    2. Narabayashi I,
    3. Matsumura K,
    4. Matsuki M,
    5. Akagi H,
    6. Ogura Y,
    7. Aga F,
    8. Adachi I
    : 2-[Fluorine-18]-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography versus whole-body diffusion-weighted MRI for detection of malignant lesions: initial experience. Ann Nucl Med 21(4): 209-215, 2007. DOI: 10.1007/s12149-007-0010-6
    OpenUrlCrossRefPubMed
  5. ↵
    1. Hopkins Medicine
    : Adrenal glands. Johns Hopkins Medicine. Available at: https://www.hopkinsmedicine.org/health/conditions-and-diseases/adrenal-glands [Last accessed on June 26, 2024]
  6. ↵
    1. Raja R,
    2. Rosenberg G,
    3. Caprihan A
    : Review of diffusion MRI studies in chronic white matter diseases. Neurosci Lett 694: 198-207, 2019. DOI: 10.1016/j.neulet.2018.12.007
    OpenUrlCrossRefPubMed
  7. ↵
    1. Kanda Y
    : Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant 48(3): 452-458, 2013. DOI: 10.1038/bmt.2012.244
    OpenUrlCrossRefPubMed
  8. ↵
    1. Teixeira SR,
    2. Elias PC,
    3. Leite AF,
    4. de Oliveira TM,
    5. Muglia VF,
    6. Elias Junior J
    : Apparent diffusion coefficient of normal adrenal glands. Radiol Bras 49(6): 363-368, 2016. DOI: 10.1590/0100-3984.2015.0045
    OpenUrlCrossRefPubMed
  9. ↵
    1. Inoue T,
    2. Kozawa E,
    3. Okada H,
    4. Inukai K,
    5. Watanabe S,
    6. Kikuta T,
    7. Watanabe Y,
    8. Takenaka T,
    9. Katayama S,
    10. Tanaka J,
    11. Suzuki H
    : Noninvasive evaluation of kidney hypoxia and fibrosis using magnetic resonance imaging. J Am Soc Nephrol 22(8): 1429-1434, 2011. DOI: 10.1681/ASN.2010111143
    OpenUrlAbstract/FREE Full Text
  10. ↵
    1. Yokota K,
    2. Sone M
    : Adrenal dysfunction in the elderly. Jpn J Geriatrics 59(2): 158-162, 2020. DOI: 10.3143/geriatrics.59.158
    OpenUrlCrossRef
  11. ↵
    1. Kerckhoffs DA,
    2. Blaak EE,
    3. Van Baak MA,
    4. Saris WH
    : Effect of aging on β-adrenergically mediated thermogenesis in men. Am J Physiol 274(6): E1075-E1079, 1998. DOI: 10.1152/ajpendo.1998.274.6.E1075
    OpenUrlCrossRef
  12. ↵
    1. Mazzeo RS,
    2. Rajkumar C,
    3. Jennings G,
    4. Esler M
    : Norepinephrine spillover at rest and during submaximal exercise in young and old subjects. J Appl Physiol 82(6): 1869-1874, 1997. DOI: 10.1152/jappl.1997.82.6.1869
    OpenUrlCrossRefPubMed
  13. ↵
    1. Sawka AM,
    2. Jaeschke R,
    3. Singh RJ,
    4. Young WF Jr.
    : A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. J Clin Endocrinol Metab 88(2): 553-558, 2003. DOI: 10.1210/jc.2002-021251
    OpenUrlCrossRefPubMed
  14. ↵
    1. Arlt W,
    2. Stewart PM
    : Adrenal corticosteroid biosynthesis, metabolism, and action. Endocrinol Metab Clin North Am 34(2): 293-313, 2005. DOI: 10.1016/j.ecl.2005.01.002
    OpenUrlCrossRefPubMed
  15. ↵
    1. Noda H,
    2. Iso H,
    3. Irie F,
    4. Sairenchi T,
    5. Ohtaka E,
    6. Ohta H
    : Gender difference of association between LDL cholesterol concentrations and mortality from coronary heart disease amongst Japanese: the Ibaraki Prefectural Health Study. J Intern Med 267(6): 576-587, 2010. DOI: 10.1111/j.1365-2796.2009.02183.x
    OpenUrlCrossRefPubMed
  16. ↵
    1. Sawada K
    : Epidemiology of dyslipidemia in women. Obstet Gynecol (Tokyo) 12: 1457-1466, 2019.
    OpenUrl
  17. ↵
    1. Ministry of Health, Labour and Welfare
    : Overview of the 2017 Patient Survey. Available at: https://www.mhlw.go.jp/english/database/db-hss/ps.html [Last accessed on July 2, 2025]
  18. ↵
    1. Otomi Y,
    2. Shinya T,
    3. Otsuka H,
    4. Terazawa K,
    5. Irahara S,
    6. Nagase S,
    7. Takahashi A,
    8. Kubo M,
    9. Harada M
    : Increased 18F-fluorodeoxyglucose accumulation in bilateral adrenal glands of the patients suffering from vasovagal reaction due to blood vessel puncture. Ann Nucl Med 30(7): 501-505, 2016. DOI: 10.1007/s12149-016-1088-5
    OpenUrlCrossRefPubMed
    1. Jinguji M,
    2. Nakajo M,
    3. Nakajo M,
    4. Nakabeppu Y,
    5. Yoshiura T
    : Vasovagal-related stress immediately before FDG injection may increase bilateral adrenal FDG uptake. Br J Radiol 89(1061): 20150950, 2016. DOI: 10.1259/bjr.20150950
    OpenUrlCrossRefPubMed
  19. ↵
    1. Koopman D,
    2. van Dalen JA,
    3. Stigt JA,
    4. Slump CH,
    5. Knollema S,
    6. Jager PL
    : Current generation time-of-flight (18)F-FDG PET/CT provides higher SUVs for normal adrenal glands, while maintaining an accurate characterization of benign and malignant glands. Ann Nucl Med 30(2): 145-152, 2016. DOI: 10.1007/s12149-015-1041-z
    OpenUrlCrossRefPubMed
  20. ↵
    1. Wada Y,
    2. Nishi M,
    3. Tokunaga T,
    4. Kashihara H,
    5. Takasu C,
    6. Yoshimoto T,
    7. Shimada M
    : Alteration of apparent diffusion coefficient measurements predict survival outcomes during neoadjuvant chemoradiotherapy in locally advanced rectal cancer. In Vivo 39(2): 927-935, 2025. DOI: 10.21873/invivo.13897
    OpenUrlAbstract/FREE Full Text
  21. ↵
    1. Heitmann F,
    2. Christ SM,
    3. March C,
    4. Pech M,
    5. Thormann M,
    6. Damm R
    : Lesion volume divided by ADC measures is an independent prognostic marker in colorectal liver metastasis treated by Y90-radioembolization. In Vivo 39(1): 292-301, 2025. DOI: 10.21873/invivo.13827
    OpenUrlAbstract/FREE Full Text
  22. ↵
    1. Dell’Atti L
    : Biparametric MRI for local staging of prostate cancer: current status and future applications. Anticancer Res 44(2): 463-470, 2024. DOI: 10.21873/anticanres.16834
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

In Vivo: 40 (1)
In Vivo
Vol. 40, Issue 1
January-February 2026
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Ed Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on In Vivo.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Investigation of the Relationship Between Adrenal Gland Signal Intensity and Age in Whole-body MRI/DWIBS
(Your Name) has sent you a message from In Vivo
(Your Name) thought you would like to see the In Vivo web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
2 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Investigation of the Relationship Between Adrenal Gland Signal Intensity and Age in Whole-body MRI/DWIBS
TOMOMI MOHRI, YUKINORI OKADA, YO UCHIYAMA, SUSUMU SAIGUSA, HIROYUKI FUJIKAWA, HIROYUKI SAKURAI, KOJI TANAKA, SEIYA WADA, MASATOMO NISHIDA, HIROMITSU UEDA, KATSUNORI TSUJII, TOMONARI GOTO, KENICHI YASUMOTO, AYAMI ZENZAI, DAIYA HAYASHI, ASUKA NAKATANI, CHIHIRO KAZAMA, KAZUHIRO SAITO
In Vivo Jan 2026, 40 (1) 364-371; DOI: 10.21873/invivo.14200

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Investigation of the Relationship Between Adrenal Gland Signal Intensity and Age in Whole-body MRI/DWIBS
TOMOMI MOHRI, YUKINORI OKADA, YO UCHIYAMA, SUSUMU SAIGUSA, HIROYUKI FUJIKAWA, HIROYUKI SAKURAI, KOJI TANAKA, SEIYA WADA, MASATOMO NISHIDA, HIROMITSU UEDA, KATSUNORI TSUJII, TOMONARI GOTO, KENICHI YASUMOTO, AYAMI ZENZAI, DAIYA HAYASHI, ASUKA NAKATANI, CHIHIRO KAZAMA, KAZUHIRO SAITO
In Vivo Jan 2026, 40 (1) 364-371; DOI: 10.21873/invivo.14200
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Patients and Methods
    • Results
    • Discussion
    • Conclusion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Signal Detection Analysis of Hypnotic-induced Respiratory Depression
  • Development and Validation of an EHR-based Algorithm for Identifying Pneumocystis jirovecii Pneumonia
  • Safety and Efficacy of SOX Therapy After Preoperative Chemoradiotherapy for Advanced Lower Rectal Cancer: A Phase I Study
Show more Clinical Studies

Keywords

  • Adrenal signal
  • hydrogen atoms
  • body imaging with background body signal suppression
  • MRI/DWIBS
  • signal intensity
In Vivo

© 2026 In Vivo

Powered by HighWire